PPBT
Purple Biotech·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 0
Bearish signal 1
Dark Cloud Cover
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About PPBT
Purple Biotech Ltd.
A biotech company that develops and commercializes novel therapies for cancer and other diseases
Pharmaceutical
08/12/1968
11/20/2015
NASDAQ Stock Exchange
9
12-31
Depository Receipts (Ordinary Shares)
4 Oppenheimer Street, Science Park, Rehovot 7670104, Israel
Bio-pharmacy.
Purple Biotech Ltd., was incorporated under the laws of the State of Israel on August 12, 1968. The company is a clinical-stage company that develops first-in-class, effective and long-lasting therapies that harness the power of TME to overcome tumor immune evasion and drug resistance.
Company Financials
EPS
PPBT has released its 2024 Q2 earnings. EPS was reported at -0.09, versus the expected -3.3, beating expectations. The chart below visualizes how PPBT has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
